Measles Vaccination Rates Dropped During COVID-19 Pandemic to 81% in 2021
The rate of children receiving a first measles-containing vaccine decreased between 2020 and 2021, CDC says.
Vaccines
COVID-19 Vaccines Up Protection More Than Infection for Moms, Infants
Antibody levels higher in maternal and cord blood after vaccination vs natural infection.
High-Dose Superior to Standard-Dose Influenza Vaccination in Older Adults
Lee EH, Lee KH, Kim J, et al. Comparing different delivery methods of fecal microbiota transplantation. Presented at: IDWeek 2022; October 19-23, 2022; Washington, DC. Poster 515.
FDA Authorizes Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted
Findings showed that the booster dose elicited robust antibody responses comparable to, or exceeding levels associated with the efficacy data in the primary series of the vaccine.
Infections Reported After Single Dose of Monkeypox Vaccine
Most of the cases of monkeypox occurring following single dose of the MVA-BN vaccine occur within 14 days.
Vaccine-Associated Aluminum Linked to Persistent Asthma in Young Children
Positive association seen for children with and without eczema; CDC is not changing current vaccine recommendations.
Trial Evaluating Pfizer’s Quadrivalent mRNA Influenza Vaccine Begins
The quadrivalent modRNA influenza vaccine candidate uses mRNA technology, which requires only the genetic sequence of the virus.
COVID-19 Boosters, Third Doses Well Tolerated Among Pregnant, Lactating People
Most individuals (82.8%) reported a local reaction after a COVID-19 booster or third dose, and 67.9% reported at least one systemic symptom.
New York Declares State Disaster Emergency Due to Circulating Polio Evidence
A State Disaster Emergency was declared in New York due to evidence of circulating poliovirus.
Maternal Vaccine Candidate for GBS Prevention in Infants Gets Breakthrough Tx Status
GBS6 is an investigational maternal vaccine designed to protect against the 6 most prominent GBS serotypes.
- Loading...
Loading...
Next post in Ob/Gyn Information Center
Loading... 
Loading...